APEX Press Releases

SALT LAKE CITY March 09, 2023, APEX Biologix, a leading regenerative medicine device company that specializes in the development of advanced patient therapies, announced today it has entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.

APEX Biologix, a leader in the regenerative medicine industry, announced today the addition of a new visionary executive to the company. Jim Rogers brings more than 20 years of creation and business development in the medical device industry to the growing team at APEX Biologix.

The new XCELL PC filter is more efficient, achieves greater concentrations, simplifies processing.

XCELL BMC to Provide System Features Specifically Designed for Surgery Settings in Hospitals, Clinics, and Surgical Centers

APEX is one of eight companies selected internationally as part of distinguished group.

The addition to the APEX team will be an asset to help them continue their growth path.

Salt Lake City, Utah, May 23, 2019 – APEX Biologix is proud to introduce an exciting new bone marrow concentration device designed to maximize mesenchymal total nucleated cell (MSC) numbers from bone marrow aspirate.

Salt Lake City, Utah, April 8, 2019 – Today, APEX Biologix formally announced the launch of their next generation and newly refined platelet rich plasma system under the 510 K number BK180252. 

Salt Lake City, Utah, September 25, 2018 – APEX Biologix would like to formally thank all their clients in making the launch of their XCELL PRP system so successful. 

Salt Lake City, Utah, July 10, 2018 – APEX Biologix formally announced today the launch of their new platelet rich plasma system. 

Salt Lake City, Utah, December 1, 2017 – Representatives from APEX Biologix, LLC are pleased to announce their new partnership with the medical business experts at Physicians Success RX.